Autonomix Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Autonomix Medical and similar public comparables like Allurion, Foresight Autonomous, Massmedica, PEPTONIC medical and more.

Autonomix Medical Overview

About Autonomix Medical

Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.


Founded

2014

HQ

United States

Employees

11

Financials (LTM)

Revenue: -
Net Income: ($16M)

Market Cap

$4M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Autonomix Medical Financials

Autonomix Medical reported last 12-month revenue of -.

In the same LTM period, Autonomix Medical generated - in gross profit and had net loss of ($16M).


Autonomix Medical P&L

In the most recent fiscal year, Autonomix Medical reported revenue of - and EBITDA of ($17M).

Autonomix Medical is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.

See analyst estimates for Autonomix Medical
LTMLast FY202320242025202620272028
EBITDA-($17M)($12M)($12M)($15M)
Net Profit($16M)($17M)($12M)($12M)($15M)

Financial data powered by Morningstar, Inc.

Autonomix Medical Stock Performance

Autonomix Medical has current market cap of $4M.


Autonomix Medical's stock price is $6.86.

Autonomix Medical has an EPS (earnings per share) of $-30.78.

See more trading valuation data for Autonomix Medical
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4M-9.0%---$-30.78

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Autonomix Medical Valuation Multiples

Autonomix Medical trades at 0.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Autonomix Medical

Autonomix Medical Financial Valuation Multiples

As of August 14, 2026, Autonomix Medical has market cap of $4M.

Autonomix Medical has a P/E ratio of (0.2x).

LTMLast FY202320242025202620272028
EV/EBITDA-0.4x0.6x0.6x0.5x
EV/EBIT0.4x0.4x1.1x0.7x0.4x
P/E(0.2x)(0.2x)(0.3x)(0.3x)(0.2x)
EV/FCF-0.6x1.3x0.9x0.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Autonomix Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Autonomix Medical Margins & Growth Rates

Autonomix Medical decreased net profit by 16% in the last fiscal year.

See estimated margins and future growth rates for Autonomix Medical

Autonomix Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
EBITDA Growth-1%26%9%
EBIT Growth(17%)73%48%(5%)
Net Profit Growth(16%)3%24%(5%)
FCF Growth-44%43%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Autonomix Medical Operational KPIs

Autonomix Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.5M for the same period.

Access forward-looking KPIs for Autonomix Medical
Last FY202620272028
Revenue per Employee$0.0M
Opex per Employee$1.5M

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Autonomix Medical Competitors

Autonomix Medical competitors include Allurion, Foresight Autonomous, Massmedica, PEPTONIC medical, Tivic Health Systems, Perpetua Medical, NexGel, SpectraCure, Sonendo and GlucoTrack.

Most Autonomix Medical public comparables operate across Medical Devices, Autonomous Tech, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Allurion1.8x-(1.0x)-
Foresight Autonomous(2.1x)(2.1x)0.1x0.1x
Massmedica0.7x-10.8x-
PEPTONIC medical2.9x-(3.1x)-
Tivic Health Systems----
Perpetua Medical0.6x-2.1x-
NexGel0.8x0.4x(4.1x)(13.2x)
SpectraCure--(0.5x)-

This data is available for Pro users. Sign up to see all Autonomix Medical competitors and their valuation data.

Start Free Trial

Autonomix Medical VC Funding History

Before going public, Autonomix Medical raised $9M in total equity funding, across 4 rounds.


Autonomix Medical Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jun-23SeedSynergy Partners International$2M--
Mar-23Pre-seed-$700K--
Apr-22Seed-$2M--
Aug-14Seed-$4M-Autonomix Medical was founded in August 2014 by Julio Toth and raised Series A funding on September 3, 2014. The company operates in the medical device space.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Autonomix Medical

When was Autonomix Medical founded?Autonomix Medical was founded in 2014.
Where is Autonomix Medical headquartered?Autonomix Medical is headquartered in United States.
How many employees does Autonomix Medical have?As of today, Autonomix Medical has over 11 employees.
Is Autonomix Medical publicly listed?Yes, Autonomix Medical is a public company listed on Nasdaq.
What is the stock symbol of Autonomix Medical?Autonomix Medical trades under AMIX ticker.
When did Autonomix Medical go public?Autonomix Medical went public in 2024.
Who are competitors of Autonomix Medical?Autonomix Medical main competitors include Allurion, Foresight Autonomous, Massmedica, PEPTONIC medical, Tivic Health Systems, Perpetua Medical, NexGel, SpectraCure, Sonendo, GlucoTrack.
What is the current market cap of Autonomix Medical?Autonomix Medical's current market cap is $4M.
Is Autonomix Medical profitable?No, Autonomix Medical is not profitable.
What is the current net income of Autonomix Medical?Autonomix Medical's last 12 months net income is ($16M).
How many companies Autonomix Medical has acquired to date?Autonomix Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Autonomix Medical has invested to date?Autonomix Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Autonomix Medical

Lists including Autonomix Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial